Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles J Sande

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Nature Communications|July 20, 2019
Author Correction: Airway response to respiratory syncytial virus has incidental antibacterial effectsCharles J Sande, James M Njunge, Joyce Mwongeli Ngoi, et al.
The Journal of Infectious Diseases|March 3, 2026
Nasopharyngeal Microbiome Composition and its Clinical Correlates in Children Hospitalized with Severe Pneumonia in East AfricaTimothy O Makori, Elijah T Gicheru, Maureen W Mburu, et al.
The Journal of Infection|February 12, 2019
Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adultsChristopher A Green, Charles J Sande, Elisa Scarselli, et al.
The Lancet. Global Health|July 9, 2026
In-hospital and post-discharge mortality among infants with respiratory syncytial virus in rural Kenya: a 25-year retrospective cohort studyMaureen W Mburu, Esther Nyadzua Katama, Mercy S Safari, et al.
Science Translational Medicine|August 14, 2015
Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adultsChristopher A Green, Elisa Scarselli, Charles J Sande, et al.
Nature Communications|November 29, 2025
Inflammation impairs post-hospital discharge growth among children hospitalised with acute illness in sub-Saharan Africa and south AsiaJames M Njunge, Evans O Mudibo, Jasper Bogaert, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Nature Communications|July 20, 2019
Author Correction: Airway response to respiratory syncytial virus has incidental antibacterial effectsCharles J Sande, James M Njunge, Joyce Mwongeli Ngoi, et al.
The Journal of Infectious Diseases|March 3, 2026
Nasopharyngeal Microbiome Composition and its Clinical Correlates in Children Hospitalized with Severe Pneumonia in East AfricaTimothy O Makori, Elijah T Gicheru, Maureen W Mburu, et al.
The Journal of Infection|February 12, 2019
Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adultsChristopher A Green, Charles J Sande, Elisa Scarselli, et al.
The Lancet. Global Health|July 9, 2026
In-hospital and post-discharge mortality among infants with respiratory syncytial virus in rural Kenya: a 25-year retrospective cohort studyMaureen W Mburu, Esther Nyadzua Katama, Mercy S Safari, et al.
Science Translational Medicine|August 14, 2015
Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adultsChristopher A Green, Elisa Scarselli, Charles J Sande, et al.
Nature Communications|November 29, 2025
Inflammation impairs post-hospital discharge growth among children hospitalised with acute illness in sub-Saharan Africa and south AsiaJames M Njunge, Evans O Mudibo, Jasper Bogaert, et al.
Pageof 3